Latest News about GILD
Recent news which mentions GILD
Acceleron In Advanced $11B Buyout Talks: Bloomberg
September 27, 2021
From Benzinga
7 Members Of Congress Failed To Disclose Stock Transactions: Who Was Named, And What's Next?
September 24, 2021
From Benzinga
3 Relatively Safe Pharma Stocks You Can Buy Right Now
September 23, 2021
From Motley Fool
NNVC Stock: What Is Going on With Red-Hot NanoViricides Today?
September 21, 2021
From InvestorPlace
EXCLUSIVE: NanoViricides' Remdesivir-Encapsulated COVID-19 Therapy Shows Encouraging Preclinical Safety Profile
September 21, 2021
From Benzinga
3 Value Stocks to Buy While You Still Can
September 20, 2021
From InvestorPlace
Barron's Latest Picks And Pans: Apple, Bitcoin, a Goldman Sachs ETF, Nike And More
September 18, 2021
From Benzinga
Baidu, Gilead Sciences And Nvidia Stocks Provide Plays For Both Bulls And Bears: Here's How
September 17, 2021
From Benzinga
The Daily Biotech Pulse: Adcom Tryst For Pfizer/BioNTech Booster Shot, AbCellera's COVID Antibody Treatment Gets Expanded Use, Protagonist Slapped With Clinical Hold
September 17, 2021
From Benzinga
Contrarian Signs Point to Possible AT&T Bull Case
September 09, 2021
From InvestorPlace
This Cancer Screening Company Has A Better 5-Year Return Than Pfizer, Johnson & Johnson And Gilead
September 06, 2021
From Benzinga
Why Investors Should Love Pfizer's Acquisition of Trillium
September 04, 2021
From Motley Fool
COVID 19 Stocks -- Vaccines, Diagnostics, or Treatments?
August 31, 2021
From Motley Fool
From Benzinga
Could Moderna Take Down Gilead Sciences?
August 30, 2021
From Motley Fool
The 3 Best Biotech Stocks to Buy Right Now
August 27, 2021
From Motley Fool
From Benzinga
7 Bargain Stocks to Buy Under $5 With the Right Catalysts
August 25, 2021
From InvestorPlace
Is It Too Late to Buy Moderna Stock?
August 25, 2021
From Motley Fool
From Benzinga
Why Trillium Therapeutics Stock Is Skyrocketing Today
August 23, 2021
From Motley Fool
Why Fate Therapeutics Stock Is Sliding Today
August 20, 2021
From Motley Fool
From Benzinga
Why NRx Pharmaceuticals Stock Jumped 11.8% Today
August 18, 2021
From Motley Fool
Why Dividend Investors Shouldn't Bother With Thermo Fisher
August 18, 2021
From Motley Fool
From Benzinga
Wall Street Journal Creates A Pitch In Favor Of Royalty Pharma
August 17, 2021
From Benzinga
Stocks That Hit 52-Week Highs On Tuesday
August 17, 2021
From Benzinga
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.